华中科技大学学报(医学版)
華中科技大學學報(醫學版)
화중과기대학학보(의학판)
ACTA UNIVERSITATIS MEDICINAE TONGJI
2009年
5期
696-699,702
,共5页
白细胞介素-6%前列腺癌
白細胞介素-6%前列腺癌
백세포개소-6%전렬선암
interleukin-6%prostate cancer
目的 探讨细胞因子白细胞介素-6(IL-6)在前列腺癌发生发展中的作用及其临床意义.方法 ①采用免疫组化SABC法和逆转录-聚合酶链反应(RT-PCR)法对前列腺癌组织及其相应的癌旁前列腺组织和前列腺癌细胞系PC-3及LNCaP中的IL-6表达进行检测;②采用酶联免疫吸附试验(ELlSA)检测前列腺癌患者及随机正常人群外周血中IL-6的浓度和前列腺癌细胞系PC-3及LNCaP培养上清液中的IL-6浓度.结果 ①前列腺癌组织中IL-6表达明显强于相应的癌旁前列腺组织,且与肿瘤的分期分级相关;PC-3细胞中IL-6呈强阳性表达,而LNCaP细胞中IL-6呈弱阳性表达.②前列腺癌患者外周血中IL-6浓度显著高于正常人群组;而PC-3细胞组培养上清液中IL-6浓度也明显高于LNCaP细胞组.结论 IL-6基因可能在前列腺癌的发生发展中起重要作用,有可能是前列腺癌从激素依赖性转化为非激素依赖性的因素之一.
目的 探討細胞因子白細胞介素-6(IL-6)在前列腺癌髮生髮展中的作用及其臨床意義.方法 ①採用免疫組化SABC法和逆轉錄-聚閤酶鏈反應(RT-PCR)法對前列腺癌組織及其相應的癌徬前列腺組織和前列腺癌細胞繫PC-3及LNCaP中的IL-6錶達進行檢測;②採用酶聯免疫吸附試驗(ELlSA)檢測前列腺癌患者及隨機正常人群外週血中IL-6的濃度和前列腺癌細胞繫PC-3及LNCaP培養上清液中的IL-6濃度.結果 ①前列腺癌組織中IL-6錶達明顯彊于相應的癌徬前列腺組織,且與腫瘤的分期分級相關;PC-3細胞中IL-6呈彊暘性錶達,而LNCaP細胞中IL-6呈弱暘性錶達.②前列腺癌患者外週血中IL-6濃度顯著高于正常人群組;而PC-3細胞組培養上清液中IL-6濃度也明顯高于LNCaP細胞組.結論 IL-6基因可能在前列腺癌的髮生髮展中起重要作用,有可能是前列腺癌從激素依賴性轉化為非激素依賴性的因素之一.
목적 탐토세포인자백세포개소-6(IL-6)재전렬선암발생발전중적작용급기림상의의.방법 ①채용면역조화SABC법화역전록-취합매련반응(RT-PCR)법대전렬선암조직급기상응적암방전렬선조직화전렬선암세포계PC-3급LNCaP중적IL-6표체진행검측;②채용매련면역흡부시험(ELlSA)검측전렬선암환자급수궤정상인군외주혈중IL-6적농도화전렬선암세포계PC-3급LNCaP배양상청액중적IL-6농도.결과 ①전렬선암조직중IL-6표체명현강우상응적암방전렬선조직,차여종류적분기분급상관;PC-3세포중IL-6정강양성표체,이LNCaP세포중IL-6정약양성표체.②전렬선암환자외주혈중IL-6농도현저고우정상인군조;이PC-3세포조배양상청액중IL-6농도야명현고우LNCaP세포조.결론 IL-6기인가능재전렬선암적발생발전중기중요작용,유가능시전렬선암종격소의뢰성전화위비격소의뢰성적인소지일.
Objective To study the role of interleukin-6(IL-6)in the pathogenesis of prostate cancer and its clinical significance. Methods Immunohistochemistry and RT-PCR were used to detect the expression of IL-6 protein and mRNA in frozen prostatic adenocarcinoma,adjacent benign prostatic tissue,and prostate cancer cell lines PC-3 and LNCaP. The serum levels of IL-6 in patients with prostate cancer and healthy controls,and the supernatants of prostate cancer cell cultures were measured by using ELISA. Results The IL-6 protein levels in prostate cancer tissue and PC-3 cells were significantly higher than those in adjacent benign prostatic tissue and LNCaP cells. The serum IL-6 levels in the patients with prostate cancer were markedly higher than those in the healthy controls. The IL-6 levels in supernatants in PC-3 cells were notably higher than those in the LNCaP cells. Conclusion The IL-6 gene may act as an important regulator in prostate cancer progression and may be one of the causes of prostate cancer conversion from an initially androgen-dependent state into an androgen-independent state.